GlassScriptPhysician profile
James E Handy
NPI 1528027992
$11,652.59
in general payments reported to CMS, 2019-2025
34 companies · $1,674 in 2025
The $1,674 reported for 2025 was more than what 88% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $109 · 2020: $468 · 2021: $1,218 · 2022: $5,335 · 2023: $2,570 · 2024: $278 · 2025: $1,674.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,387 · Travel and Lodging: $2,115 · Debt Forgiveness: $18.89.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,387.44 |
| Travel and Lodging | $2,115.31 |
| Debt Forgiveness | $18.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $4,022.86 | 2021-2025 | Prostep, Sonicfusion, Variax |
| Arthrex, INC. | $3,259.78 | 2022-2025 | |
| Anika Therapeutics, INC. | $1,180.76 | 2021-2025 | Tactoset, X-Twist, Integrity Implant |
| Medinc of Texas | $788.79 | 2020-2022 | |
| Core Surgical Group | $701.83 | 2025 | |
| Ossio INC | $216.06 | 2022-2023 | |
| Treace Medical Concepts, INC. | $204.06 | 2022-2025 | |
| Lilly USA, LLC | $173.29 | 2022-2025 | Mounjaro, Zepbound |
| Boehringer Ingelheim Pharmaceuticals, INC. | $147.80 | 2022-2025 | Jardiance, Synjardy, Tradjenta |
| Medtronic, INC. | $139.13 | 2023 | Vanta Adaptivestim, Intellis Adaptivestim |
| Pfizer INC. | $103.60 | 2022-2025 | |
| Abiomed | $89.01 | 2020-2024 | Impella |
| Cmp Pharma, INC. | $83.79 | 2022 | |
| Smith+Nephew, INC. | $67.17 | 2020-2021 | |
| Abbott Laboratories | $50.11 | 2023-2024 | Proclaim, Freestyle Libre 3 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Trimed, INC. | $36.55 | 2022 | |
| Exact Sciences Corporation | $34.82 | 2023-2024 | Cologuard Collection Kit |
| Wound Management Technologies, INC | $33.94 | 2019 | |
| Kyowa Kirin, INC. | $33.55 | 2025 | |
| Idorsia Pharmaceuticals US INC | $32.65 | 2023 | Quviviq |
| Amgen INC. | $27.41 | 2019-2025 | Evenity, Prolia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $27.17 | 2019-2020 | |
| Novo Nordisk INC | $21.84 | 2025 | |
| Mylan Specialty L.P. | $19.30 | 2021 | |
| Baxter Healthcare | $18.89 | 2025 | |
| Cranial Technologies, INC | $17.79 | 2021 | |
| Averitas Pharma INC. | $16.23 | 2023 | Qutenza |
| Genentech USA, INC. | $16.00 | 2019 | |
| Bioventus LLC | $15.30 | 2019 | |
| Antares Pharma, INC. | $15.20 | 2022 | |
| Merck Sharp & Dohme LLC | $14.93 | 2019 | |
| Shield Therapeutics INC | $14.78 | 2022 | |
| Ibsa Pharma INC. | $14.30 | 2021 | |
| Spinal Simplicity, LLC | $13.90 | 2025 | Ha Minuteman G3-R |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Handy listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.